True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
intestinal enteroendocrine cell,Enteroendocrine Cells,"L-cells, Enterochromaffin (EC) cells, Other Enteroendocrine Subtypes (e.g., S-cells, D-cells, K-cells)",L-cells with a potential admixture or co-expression of EC cell characteristics,50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: As a professional computational biologist, I will meticulously analyze the provided ranked marker list from a single-cell RNA sequencing dataset of human large intestine tissue to identify the cell type. I will follow a step-by-step approach to ensure a comprehensive and accurate annotation.

**Marker List:** GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8

---

**1. List the Key Functional Markers:**

This step focuses on genes that indicate specific cellular processes, pathways, or secreted products.

*   **GCG (Glucagon):** Encodes proglucagon, which is processed into glucagon, a hormone primarily known for regulating glucose homeostasis. In the intestine, proglucagon can also be processed into GLP-1 and GLP-2, important for gut hormone signaling and intestinal growth.
*   **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** A proprotein convertase involved in the proteolytic processing of prohormones and proneuropeptides into their biologically active forms. Essential for the maturation of many peptide hormones, including glucagon, PYY, and insulin.
*   **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone (CRH) family. Involved in stress response, appetite regulation, and gastrointestinal motility.
*   **PYY (Peptide YY):** A peptide hormone secreted by enteroendocrine cells in the gut in response to food intake. It plays a crucial role in satiety, energy homeostasis, and gut motility.
*   **INSL5 (Insulin-like 5):** A peptide hormone primarily expressed in enteroendocrine cells, particularly L-cells. Its function is still being elucidated but is implicated in gut-brain axis signaling and colonic motility.
*   **CHGA (Chromogranin A):** A major soluble protein found in the secretory vesicles of neuroendocrine cells. It serves as a general marker for neuroendocrine differentiation and is involved in the packaging and storage of peptide hormones.
*   **SCG2 (Secretogranin II):** Another member of the chromogranin/secretogranin family, also found in neuroendocrine secretory granules. Involved in the processing and storage of peptide hormones.
*   **FEV (FEV Transcription Factor):** A transcription factor involved in the development and differentiation of specific neuronal and neuroendocrine cell types.
*   **CPLX2 (Complexin 2):** A cytosolic protein involved in synaptic vesicle exocytosis, regulating neurotransmitter release. Its presence suggests a role in regulated secretion.
*   **NKX2-2 (NK2 Homeobox 2):** A homeodomain transcription factor crucial for the development and differentiation of various neuroendocrine cell types, including pancreatic islet cells and enteroendocrine cells.
*   **SCGN (Secretagogin):** A calcium-binding protein expressed in neuroendocrine cells, involved in regulated exocytosis.
*   **SLC18A1 (Solute Carrier Family 18 Member A1, Vesicular Monoamine Transporter 1 - VMAT1):** Involved in the transport of monoamines (like serotonin) into synaptic vesicles. Its presence suggests the ability to store and release monoamine neurotransmitters/hormones.
*   **SCG3 (Secretogranin III):** Another secretogranin family member, involved in neuroendocrine secretion.
*   **SCG5 (Secretogranin V, NESP55):** Another secretogranin family member, involved in neuroendocrine secretion.
*   **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme in serotonin biosynthesis. Its presence indicates the ability to produce serotonin.
*   **INSM1 (Insulinoma-associated 1):** A transcription factor essential for neuroendocrine differentiation and development.
*   **SNAP25 (Synaptosomal-Associated Protein 25):** A component of the SNARE complex, crucial for membrane fusion and exocytosis, particularly in neurons and neuroendocrine cells.
*   **CHGB (Chromogranin B):** Another member of the chromogranin family, similar to CHGA, indicating neuroendocrine characteristics.
*   **SLC32A1 (Solute Carrier Family 32 Member A1, Vesicular GABA Transporter - VGAT):** Transports GABA and glycine into synaptic vesicles. Its presence suggests the ability to store and release inhibitory neurotransmitters.
*   **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes SUR1, a subunit of the ATP-sensitive potassium channel (KATP channel). KATP channels are critical for glucose-stimulated insulin secretion in pancreatic beta cells and are also found in other neuroendocrine cells, regulating excitability and hormone release.
*   **SCT (Secretin):** A peptide hormone secreted by S cells in the duodenum in response to acidic chyme. While primarily duodenal, its presence suggests enteroendocrine lineage.
*   **ARX (Aristaless Related Homeobox):** A transcription factor involved in the development of various neuroendocrine cell types, including pancreatic alpha cells and some enteroendocrine cells.
*   **PRPH (Peripherin):** An intermediate filament protein found in peripheral neurons and some neuroendocrine cells.
*   **INA (Internexin Alpha):** An intermediate filament protein found in neurons.
*   **SLC5A8 (Solute Carrier Family 5 Member A8, Sodium-coupled monocarboxylate transporter 1 - SMCT1):** Involved in the transport of short-chain fatty acids and monocarboxylates. Its role in enteroendocrine cells is less direct but can be related to nutrient sensing.

**Summary of Functional Markers:** The overwhelming presence of genes involved in hormone synthesis (GCG, PYY, INSL5, UCN3, SCT, TPH1), processing (PCSK1), packaging (CHGA, CHGB, SCG2, SCG3, SCG5), and regulated secretion (CPLX2, SNAP25, SLC18A1, SLC32A1, ABCC8) strongly points towards a neuroendocrine cell type. Transcription factors like FEV, NKX2-2, INSM1, and ARX further support this, as they are critical for neuroendocrine cell development and differentiation.

---

**2. List the Key Cell Type Markers:**

This step focuses on genes that are known to be specific to certain cell types within the large intestine or broader tissue contexts.

*   **GCG (Glucagon):** In the intestine, GCG is a definitive marker for L-cells, which produce GLP-1, GLP-2, and PYY.
*   **PYY (Peptide YY):** A hallmark marker for L-cells in the intestine.
*   **INSL5 (Insulin-like 5):** Highly specific marker for L-cells, particularly in the colon.
*   **UCN3 (Urocortin 3):** Expressed in a subset of enteroendocrine cells, including some L-cells and other neuroendocrine populations.
*   **CHGA (Chromogranin A):** A pan-neuroendocrine marker, indicating the general class of cells.
*   **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** While functional, its high expression is characteristic of cells that produce and process peptide hormones, a key feature of enteroendocrine cells.
*   **NKX2-2 (NK2 Homeobox 2):** A critical transcription factor for enteroendocrine cell development and maintenance.
*   **INSM1 (Insulinoma-associated 1):** A master regulator of neuroendocrine differentiation, highly expressed in all developing and mature enteroendocrine cells.
*   **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme for serotonin synthesis, a key marker for enterochromaffin (EC) cells.
*   **SCT (Secretin):** A marker for S cells, primarily found in the duodenum, but its presence suggests a broader enteroendocrine lineage.
*   **ARX (Aristaless Related Homeobox):** A transcription factor involved in the specification of various enteroendocrine cell types, including L-cells and K-cells.
*   **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** While also functional, its presence, particularly in conjunction with other markers, can indicate a cell type with regulated hormone release mechanisms similar to pancreatic beta cells, which is characteristic of enteroendocrine cells.
*   **SLC18A1 (VMAT1):** Expressed in enterochromaffin (EC) cells for serotonin packaging.
*   **SLC32A1 (VGAT):** While more common in neurons, its presence in some enteroendocrine cells has been reported, suggesting potential co-release of neurotransmitters.

**Summary of Cell Type Markers:** The combination of GCG, PYY, INSL5, UCN3, CHGA, PCSK1, NKX2-2, INSM1, and TPH1 is highly indicative of **enteroendocrine cells**. The specific combination of GCG, PYY, and INSL5 points strongly towards L-cells, while TPH1 suggests the presence of EC cells. The general neuroendocrine markers (CHGA, PCSK1, INSM1) confirm the overall identity.

---

**3. Cross-reference Known Databases:**

I would use resources like:

*   **PanglaoDB:** A comprehensive database of scRNA-seq markers. Searching for ""enteroendocrine cells"" or specific gut cell types would confirm the presence of these markers.
*   **CellMarker:** Another database for cell type-specific markers.
*   **Human Cell Atlas (HCA) Data Portals:** Exploring large intestine datasets within HCA would provide context on marker expression in different cell types.
*   **Literature Search (PubMed/Google Scholar):** Searching for ""large intestine enteroendocrine cell markers,"" ""L-cell markers,"" ""EC cell markers,"" etc., would validate the findings.

**Expected Findings from Databases:**
Databases and literature consistently show that GCG, PYY, INSL5, CHGA, PCSK1, NKX2-2, INSM1, and TPH1 are canonical markers for enteroendocrine cells in the gut. Specifically, GCG, PYY, and INSL5 are highly enriched in L-cells, while TPH1 is a defining marker for EC cells. The presence of multiple secretogranins (SCG2, SCG3, SCG5) and SNARE complex components (CPLX2, SNAP25) further reinforces the neuroendocrine secretory phenotype.

---

**4. Determine the Most Probable General Cell Type:**

Based on the comprehensive analysis of both functional and cell-type specific markers, the most probable general cell type is **Enteroendocrine Cells**.

**Reasoning:**
The expression profile is a classic signature of neuroendocrine cells, characterized by:
*   **Hormone Production:** GCG, PYY, INSL5, UCN3, SCT, TPH1.
*   **Hormone Processing & Packaging:** PCSK1, CHGA, CHGB, SCG2, SCG3, SCG5.
*   **Regulated Secretion Machinery:** CPLX2, SNAP25, SLC18A1, SLC32A1, ABCC8.
*   **Neuroendocrine Transcription Factors:** FEV, NKX2-2, INSM1, ARX.

These markers collectively define the specialized secretory function of enteroendocrine cells, which are dispersed throughout the gastrointestinal epithelium and play a vital role in sensing luminal contents and regulating digestion, metabolism, and gut motility through hormone release.

---

**5. Identify the Top 3 Most Probable Sub Cell Types:**

Within the general category of enteroendocrine cells, there are several subtypes, each characterized by a unique hormone profile.

1.  **Most Likely Subtype: L-cells**
    *   **Key Markers:** **GCG, PYY, INSL5, UCN3**. The co-expression and high ranking of these markers are highly specific to L-cells. L-cells are known to produce proglucagon-derived peptides (GLP-1, GLP-2) from GCG, as well as PYY and INSL5. UCN3 is also found in a subset of L-cells.
    *   **Supporting Markers:** PCSK1 (for prohormone processing), CHGA/CHGB (general neuroendocrine markers), NKX2-2, INSM1, ARX (transcription factors involved in L-cell development).

2.  **Second Most Likely Subtype: Enterochromaffin (EC) cells**
    *   **Key Marker:** **TPH1**. TPH1 is the rate-limiting enzyme for serotonin synthesis, the primary hormone produced by EC cells.
    *   **Supporting Markers:** SLC18A1 (VMAT1, for serotonin packaging), CHGA/CHGB (general neuroendocrine markers), SNAP25 (for regulated secretion). While TPH1 is present, its ranking is lower than the L-cell specific markers, suggesting L-cells are more dominant in this cluster, or it represents a mixed population.

3.  **Third Most Likely Subtype: Other Enteroendocrine Subtypes (e.g., S-cells, D-cells, K-cells)**
    *   **Key Marker:** **SCT (Secretin)**. Secretin is the defining hormone for S-cells. Its presence, though lower in the list, indicates the potential for a minor S-cell population or a broader enteroendocrine progenitor/differentiated state that can express multiple hormones.
    *   **Supporting Markers:** General neuroendocrine markers (CHGA, PCSK1, INSM1) would be present in these cells as well. The absence of strong, specific markers for other types (e.g., SST for D-cells, GIP for K-cells) makes them less likely as primary components of this cluster.

**Most Likely Subtype based on markers:**
The most likely specific subtype is **L-cells**, given the prominent and highly ranked expression of GCG, PYY, and INSL5. The presence of TPH1 suggests that this cluster might also contain a significant proportion of EC cells, or it could represent a mixed enteroendocrine population, or even a single cell type with co-expression of multiple hormones, which is increasingly recognized in enteroendocrine cells. However, the top markers strongly favor L-cells.

---

**6. Provide a Concise Summary of Your Analysis:**

The single-cell cluster from human large intestine tissue is confidently identified as **Enteroendocrine Cells**. This annotation is strongly supported by the high and consistent expression of canonical neuroendocrine markers, including hormones (GCG, PYY, INSL5, UCN3, TPH1, SCT), prohormone processing enzymes (PCSK1), secretory granule components (CHGA, CHGB, SCG2, SCG3, SCG5), and key transcription factors essential for neuroendocrine differentiation (NKX2-2, INSM1, FEV, ARX). The machinery for regulated secretion (CPLX2, SNAP25, SLC18A1, SLC32A1, ABCC8) further reinforces this identity.

Within the enteroendocrine cell population, the most prominent subtype indicated by the marker list is **L-cells**, due to the high expression of GCG, PYY, and INSL5. The presence of TPH1 suggests a significant contribution from or co-occurrence with Enterochromaffin (EC) cells. Other enteroendocrine subtypes, such as S-cells (indicated by SCT), appear to be less dominant in this specific cluster. Therefore, this cluster primarily represents **L-cells with a potential admixture or co-expression of EC cell characteristics**.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED. | Formatting Agent: ```json
{
  ""main_cell_type"": ""Enteroendocrine Cells"",
  ""sub_cell_types"": [
    ""L-cells"",
    ""Enterochromaffin (EC) cells"",
    ""Other Enteroendocrine Subtypes (e.g., S-cells, D-cells, K-cells)""
  ],
  ""possible_mixed_cell_types"": [
    ""L-cells with a potential admixture or co-expression of EC cell characteristics""
  ]
}
```"
plasma cell,Plasma Cells,"Plasma Cells, Plasmablasts, Activated B Cells",,50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: As a professional computational biologist, I will meticulously analyze the provided ranked list of marker genes to identify the cell type from a human large intestine tissue single-cell dataset.

**Step-by-Step Analysis:**

**1. List the Key Functional Markers:**

This list is dominated by immunoglobulin (IG) genes. These genes are crucial for the adaptive immune system, specifically for antibody production.

*   **IGLL5, IGLV6-57, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHV3-74, IGHM, IGKV3-20, IGHA2:** These are all immunoglobulin light chain (IGL, IGK) and heavy chain (IGH) variable (V) and constant (C) region genes. Their high expression is a hallmark of cells actively producing and secreting antibodies.
*   **JCHAIN:** This gene encodes the J chain, a small polypeptide that links monomeric immunoglobulin units (IgM and IgA) into their polymeric forms (pentameric IgM and dimeric IgA). Its presence strongly indicates the production of polymeric antibodies.
*   **TNFRSF17 (BCMA - B-cell maturation antigen):** A receptor for BAFF and APRIL, crucial for plasma cell survival and differentiation. Its expression is characteristic of plasma cells.
*   **MZB1 (Marginal zone B and B1 cell specific protein):** While initially associated with marginal zone B cells, MZB1 is also highly expressed in plasma cells, where it plays a role in protein folding and secretion in the endoplasmic reticulum, supporting high antibody production.
*   **DERL3 (Derlin 3):** Involved in ER-associated degradation (ERAD), a pathway essential for quality control of proteins in the endoplasmic reticulum. High expression is consistent with cells having a highly active ER, such as antibody-secreting cells.
*   **GPRC5D (G protein-coupled receptor class C group 5 member D):** While its exact function in plasma cells is still being elucidated, it has been identified as a plasma cell-specific surface marker and a target for multiple myeloma therapies.
*   **FCRL5 (Fc receptor-like 5):** An inhibitory Fc receptor expressed on B cells and plasma cells, involved in regulating immune responses. Its presence further supports a B cell/plasma cell lineage.
*   **TXNDC5 (Thioredoxin domain containing 5):** Involved in protein folding and disulfide bond formation in the ER, consistent with high protein (antibody) synthesis.

**2. List the Key Cell Type Markers:**

Based on the functional markers, the cell type markers are overwhelmingly indicative of antibody-secreting cells.

*   **IG genes (IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MZB1, IGHG3, IGHV3-74, IGHM, IGKV3-20, IGHA2):** These are the definitive markers for B cell lineage, specifically terminally differentiated antibody-secreting cells. The presence of multiple heavy chain isotypes (IGHG1, IGHG3, IGHA1, IGHA2, IGHM) indicates isotype switching, a characteristic of mature B cells and plasma cells.
*   **TNFRSF17 (BCMA):** A well-established marker for plasma cells.
*   **MZB1:** Highly expressed in plasma cells.
*   **GPRC5D:** A relatively specific marker for plasma cells.
*   **FCRL5:** Found on B cells and plasma cells.
*   **CCL3 (MIP-1α):** A chemokine that can be produced by various immune cells, including plasma cells, and is involved in immune cell recruitment. Its presence here is supportive but not definitive on its own.
*   **LILRB4 (ILT3):** An inhibitory receptor expressed on myeloid cells, but also found on some B cell subsets and plasma cells, where it can modulate immune responses.

**Genes less specific or potentially related to cellular processes:**

*   **FAM92B, AC026369.3, AC104699.1, LINC02362, AL391056.1, UBE2QL1, LINC00309, AL133467.1, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, LINC02384, ANKRD36BP2, AMPD1, MYL2, BMP6, CCR10, BFSP2, APOBEC3A, AC106897.1:** Many of these are uncharacterized lncRNAs, pseudogenes, or genes with broader expression patterns (e.g., MYL2 - myosin light chain 2, often associated with muscle, but could be low-level or non-specific in this context; AMPD1 - AMP deaminase 1, involved in purine metabolism). Their high ranking suggests they might be co-expressed or have a yet-to-be-defined role in this specific cell type, or simply represent highly expressed background genes. However, they do not contradict the strong signal from the immunoglobulin and plasma cell markers.

**3. Cross-reference Known Databases:**

A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) for the top markers like IGLL5, JCHAIN, IGHG1, IGHM, IGHA1, TNFRSF17, MZB1, GPRC5D consistently points to **plasma cells** as the primary cell type. The co-expression of multiple immunoglobulin heavy chain isotypes (IgG, IgA, IgM) and the J chain is a definitive signature of plasma cells actively secreting diverse antibodies.

**4. Determine the Most Probable General Cell Type:**

Based on the overwhelming expression of immunoglobulin genes (heavy and light chains, various isotypes), JCHAIN, TNFRSF17 (BCMA), MZB1, and GPRC5D, the most probable general cell type is **B-lymphocyte lineage, specifically terminally differentiated antibody-secreting cells.**

**5. Identify the Top 3 Most Probable Sub Cell Types:**

Given the context of the large intestine, which is rich in immune cells and a site of active immune responses, the sub-types are highly relevant.

1.  **Plasma Cells (most likely):** The presence of TNFRSF17 (BCMA), MZB1, GPRC5D, and the extensive array of immunoglobulin genes (including multiple isotypes like IgG, IgA, IgM, and JCHAIN for polymeric forms) is the quintessential signature of plasma cells. Plasma cells are terminally differentiated B cells specialized in high-rate antibody secretion. The large intestine, particularly the lamina propria, is known to harbor a significant population of plasma cells, especially IgA-secreting ones, crucial for mucosal immunity. The presence of IGHA1 and IGHA2 strongly supports IgA-secreting plasma cells, which are abundant in the gut.
2.  **Plasmablasts:** These are activated B cells that have begun to differentiate into plasma cells but are not yet fully mature. They also express high levels of immunoglobulin genes and can secrete antibodies, but might retain some B cell markers (which are not prominently seen here, suggesting a more mature state). However, the distinction between plasmablasts and plasma cells can be a continuum, and this cluster leans heavily towards the more mature, antibody-secreting phenotype.
3.  **Activated B Cells (less likely):** While activated B cells express immunoglobulin genes, they typically do not show the same high levels of JCHAIN, TNFRSF17, MZB1, and the sheer diversity and quantity of secreted immunoglobulin isotypes as seen here. Activated B cells are precursors to plasma cells and would likely have a different marker profile, perhaps retaining more B cell receptor components and co-stimulatory molecules.

**Most Likely Subtype:**

The most likely subtype is **Plasma Cells**, specifically **IgA-secreting Plasma Cells**, given the high expression of IGHA1 and IGHA2, which are critical for mucosal immunity in the large intestine. The presence of JCHAIN further supports the production of dimeric IgA.

**6. Provide a Concise Summary of Your Analysis:**

This cell cluster from the human large intestine is definitively identified as **Plasma Cells**. The annotation is strongly supported by the overwhelming expression of numerous immunoglobulin heavy and light chain genes (IGLL5, IGLV6-57, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHV3-74, IGHM, IGKV3-20, IGHA2), indicating active antibody synthesis and secretion. Key specific markers such as **JCHAIN** (for polymeric antibody formation), **TNFRSF17 (BCMA)**, **MZB1**, and **GPRC5D** further confirm the plasma cell identity. The prominent expression of **IGHA1** and **IGHA2** suggests a significant population of IgA-secreting plasma cells, which are crucial for maintaining mucosal immunity in the large intestine.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED. | Formatting Agent: ```json
{
  ""main_cell_type"": ""Plasma Cells"",
  ""sub_cell_types"": [
    ""Plasma Cells"",
    ""Plasmablasts"",
    ""Activated B Cells""
  ],
  ""possible_mixed_cell_types"": []
}
```"
transit amplifying cell of large intestine,Proliferating Cells,"Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs) in Proliferative State, Activated Fibroblasts / Mesenchymal Cells",,50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,N/A,"Final Annotation Agent: As a professional computational biologist, I will meticulously analyze the provided list of highly expressed markers to identify the cell type from a human large intestine tissue single-cell dataset. I will follow the outlined steps to provide a comprehensive and specific analysis.

**Input Marker List (ranked by expression intensity, high to low):**
HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2

---

**1. List the Key Functional Markers:**

This list is overwhelmingly enriched with genes involved in cell cycle progression, DNA replication, and mitosis.

*   **Cell Cycle Regulation & Mitosis:**
    *   **MKI67 (Marker of Proliferation Ki-67):** A classic and widely used marker for cell proliferation, expressed during active phases of the cell cycle (G1, S, G2, M) but absent in G0. Its high ranking is a strong indicator of proliferating cells.
    *   **CDK1 (Cyclin Dependent Kinase 1):** A key regulator of the G2/M transition and mitosis.
    *   **CCNB2 (Cyclin B2):** A mitotic cyclin, essential for entry into and progression through mitosis.
    *   **PLK1 (Polo-like Kinase 1):** Crucial for multiple mitotic events, including centrosome maturation, spindle assembly, and cytokinesis.
    *   **AURKB (Aurora Kinase B):** A key regulator of chromosome segregation and cytokinesis.
    *   **BIRC5 (Survivin):** An anti-apoptotic protein and a key component of the chromosomal passenger complex, essential for proper chromosome segregation and cytokinesis.
    *   **TOP2A (DNA Topoisomerase II Alpha):** Involved in DNA replication and chromosome segregation during mitosis.
    *   **FOXM1 (Forkhead Box M1):** A transcription factor that regulates the expression of many genes involved in cell cycle progression, particularly in G2/M phase. Often referred to as a ""master regulator"" of mitosis.
    *   **CDC25C (Cell Division Cycle 25C):** A phosphatase that activates CDK1, promoting entry into mitosis.
    *   **TTK (TTK Protein Kinase):** A key component of the spindle assembly checkpoint (SAC), ensuring proper chromosome segregation.
    *   **NEK2 (NIMA Related Kinase 2):** Involved in centrosome separation and spindle formation.
    *   **NCAPG (Non-SMC Condensin I Complex Subunit G):** A subunit of the condensin complex, essential for chromosome condensation.
    *   **PIMREG (PIM Kinase Regulator):** Involved in cell cycle progression.
    *   **CDT1 (Chromatin Licensing And DNA Replication Factor 1):** Essential for DNA replication initiation, ensuring DNA is replicated only once per cell cycle.
    *   **CCNA2 (Cyclin A2):** Involved in both S phase progression and G2/M transition.

*   **Kinesin Family Members (Mitotic Spindle Function):**
    *   **KIF2C (Kinesin Family Member 2C):** Involved in spindle dynamics and chromosome segregation.
    *   **KIF15 (Kinesin Family Member 15):** Plays a role in spindle assembly and maintenance.
    *   **KIF18B (Kinesin Family Member 18B):** Involved in chromosome alignment and segregation.

*   **Centrosome & Spindle Assembly:**
    *   **CENPA (Centromere Protein A):** A histone H3 variant specific to centromeres, crucial for kinetochore assembly.
    *   **ASPM (Abnormal Spindle Microtubule Assembly):** Essential for normal spindle function and neurogenesis.
    *   **CEP55 (Centrosomal Protein 55):** Involved in cytokinesis.
    *   **SPC25 (Spindle Pole Body Component 25 Homolog):** A component of the NDC80 kinetochore complex, essential for chromosome segregation.
    *   **SPC24 (Spindle Pole Body Component 24 Homolog):** Another component of the NDC80 kinetochore complex.
    *   **NUF2 (NUF2 Kinetochore Complex Component):** Part of the NDC80 complex.
    *   **SKA3 (Spindle And Kinetochore Associated Complex Subunit 3):** Part of the SKA complex, essential for stable kinetochore-microtubule attachments.
    *   **SKA1 (Spindle And Kinetochore Associated Complex Subunit 1):** Another subunit of the SKA complex.

*   **DNA Replication & Repair:**
    *   **RRM2 (Ribonucleotide Reductase M2):** Catalyzes the rate-limiting step in dNTP synthesis, essential for DNA replication.
    *   **GINS2 (GINS Complex Subunit 2):** A component of the GINS complex, essential for DNA replication fork progression.
    *   **RAD51AP1 (RAD51 Associated Protein 1):** Involved in homologous recombination and DNA repair.
    *   **TK1 (Thymidine Kinase 1):** Involved in the salvage pathway for dNTP synthesis, highly expressed in proliferating cells.
    *   **POLQ (DNA Polymerase Theta):** Involved in DNA repair, particularly alternative end-joining.

*   **Other Mitotic/Proliferation-Associated Genes:**
    *   **HJURP (Holliday Junction Recognition Protein):** Involved in CENP-A deposition at centromeres.
    *   **UBE2C (Ubiquitin Conjugating Enzyme E2 C):** Involved in ubiquitin-mediated proteolysis, crucial for cell cycle progression, particularly anaphase.
    *   **PBK (PDZ Binding Kinase):** Involved in cell proliferation and mitosis.
    *   **DLGAP5 (DLG Associated Protein 5):** Involved in spindle organization and cytokinesis.
    *   **CKAP2L (Cytoskeleton Associated Protein 2 Like):** Involved in microtubule organization.
    *   **DEPDC1 (DEP Domain Containing 1):** Involved in cell proliferation.
    *   **CDC45 (Cell Division Cycle 45):** Essential for DNA replication initiation and elongation.
    *   **CDCA5 (Cell Division Cycle Associated 5):** Involved in chromosome condensation and segregation.
    *   **PCLAF (PCNA Clamp Associated Factor):** Involved in DNA replication and repair.
    *   **MND1 (Meiotic Nuclear Division 1 Homolog):** Involved in homologous recombination and DNA repair.
    *   **ZNF695 (Zinc Finger Protein 695):** Less directly characterized in cell cycle, but often co-expressed with proliferation markers.
    *   **DTL (Denticleless E3 Ubiquitin Protein Ligase Homolog):** Involved in DNA damage response and cell cycle control.
    *   **PKMYT1 (Protein Kinase, Membrane Associated Tyrosine/Threonine 1):** Inhibits CDK1, involved in G2/M checkpoint.
    *   **CDCA3 (Cell Division Cycle Associated 3):** Involved in cell cycle progression.
    *   **DIAPH3 (Diaphanous Related Formin 3):** Involved in actin cytoskeleton organization, important for cytokinesis.
    *   **IQGAP3 (IQ Motif And GAP Related Protein 3):** Involved in cell proliferation and migration.
    *   **GTSE1 (G2 And S Phase Expressed 1):** Involved in cell cycle regulation.
    *   **OIP5 (OPA Interacting Protein 5):** Involved in cell cycle progression.
    *   **TROAP (Trophinin Associated Protein):** Involved in cell division.

**Summary of Functional Markers:** The overwhelming majority of the listed genes are directly involved in various aspects of cell division, including DNA replication, chromosome condensation, spindle formation, chromosome segregation, and cytokinesis. This strongly points towards a highly proliferative cell population.

---

**2. List the Key Cell Type Markers:**

Given the functional markers, the primary ""cell type"" marker here is **MKI67**, which is a universal marker for proliferating cells, rather than a specific differentiated cell type.

*   **MKI67:** As discussed, this is the most prominent cell type-agnostic proliferation marker. Its high expression indicates cells actively undergoing division.

The other markers are primarily cell cycle machinery components, not specific markers of a particular differentiated cell lineage within the large intestine. Therefore, we are looking for a cell type that is inherently proliferative.

---

**3. Cross-reference Known Databases:**

A quick search of these markers (e.g., using GeneCards, Human Protein Atlas, or scRNA-seq atlases like CellMarker, PanglaoDB, or specific large intestine scRNA-seq datasets) consistently links them to cell cycle and proliferation.

*   **MKI67, TOP2A, BIRC5, AURKB, KIF2C, KIF15, KIF18B, CENPA, ASPM, UBE2C, CDK1, CCNB2, PLK1, FOXM1, RRM2, TK1, CDC45, CDT1, CCNA2, CDC25C, TTK, NUF2, SKA3, SPC25, SPC24, CEP55, DLGAP5, PBK, HJURP, DEPDC1, CDCA5, PCLAF, MND1, ZNF695, DTL, PKMYT1, CDCA3, DIAPH3, IQGAP3, GTSE1, OIP5, TROAP, SKA1, NEK2, NCAPG, PIMREG, GINS2, RAD51AP1, CKAP2L:** All these genes are well-established markers of cell cycle activity and are commonly found in proliferating cell clusters across various tissues.

In the context of the large intestine, highly proliferative cells are typically found in the crypts, where stem cells and their rapidly dividing progeny reside.

---

**4. Determine the Most Probable General Cell Type:**

Based on the overwhelming enrichment of cell cycle and proliferation-associated genes, the most probable general cell type is **Proliferating Cells**. These are cells actively undergoing division.

---

**5. Identify the Top 3 Most Probable Sub Cell Types:**

In the large intestine, the primary source of proliferating cells is within the crypts of Lieberkühn. These crypts contain intestinal stem cells (ISCs) and their rapidly dividing progenitor cells (transit-amplifying cells).

1.  **Most Likely: Transit-Amplifying (TA) Cells / Progenitor Cells:**
    *   **Reasoning:** TA cells are highly proliferative, undergoing rapid rounds of division to generate the various differentiated cell types of the intestinal epithelium. The extensive list of cell cycle genes perfectly matches the high proliferative capacity of these cells. ISCs also proliferate, but TA cells represent the bulk of the rapidly dividing population in the crypt. The markers are indicative of active, rapid cell division, which is the hallmark of TA cells.

2.  **Second Most Likely: Intestinal Stem Cells (ISCs) in Proliferative State:**
    *   **Reasoning:** ISCs (e.g., Lgr5+ stem cells) are the ultimate source of all intestinal epithelial cells and are inherently proliferative. While they also express cell cycle genes, the sheer breadth and high expression of so many mitotic genes suggest a population that is *primarily* defined by its proliferative activity, which is more characteristic of the TA cell compartment that is rapidly expanding from the stem cell pool. However, a subset of ISCs would also be captured in this cluster.

3.  **Third Most Likely: Activated Fibroblasts / Mesenchymal Cells (if undergoing repair/regeneration):**
    *   **Reasoning:** While less likely given the sheer number of *epithelial-specific* proliferation markers (which are not explicitly present, but the context of large intestine implies epithelial turnover), fibroblasts can proliferate during wound healing or inflammation. However, their proliferative signature would typically be accompanied by markers of mesenchymal origin (e.g., COL1A1, ACTA2, PDGFRA), which are absent here. The provided markers are universally associated with cell cycle machinery, not specific to mesenchymal proliferation. Therefore, this is a distant third, primarily considered if the primary epithelial candidates were ruled out.

**Most Likely Subtype:** **Transit-Amplifying (TA) Cells**

---

**6. Provide a Concise Summary of Your Analysis:**

The provided marker list is overwhelmingly enriched for genes involved in cell cycle progression, DNA replication, and mitosis (e.g., MKI67, TOP2A, BIRC5, AURKB, KIF2C, CDK1, CCNB2, PLK1, FOXM1, RRM2, TK1). This robust signature unequivocally identifies the cluster as a population of highly **proliferating cells**. In the context of the human large intestine, such a highly proliferative population is characteristic of the intestinal crypts. Therefore, the most probable general cell type is **Proliferating Cells**. Within the large intestine, the top three most probable sub cell types are: 1) **Transit-Amplifying (TA) Cells** (most likely, due to their rapid and extensive division), 2) Intestinal Stem Cells (ISCs) in a proliferative state, and 3) Activated Fibroblasts/Mesenchymal Cells (least likely, as the markers are general cell cycle rather than mesenchymal-specific). Based on the comprehensive and strong proliferative signature, the cluster is most accurately annotated as **Transit-Amplifying (TA) Cells**.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED. | Formatting Agent: ```json
{
""main_cell_type"": ""Proliferating Cells"",
""sub_cell_types"": [
""Transit-Amplifying (TA) Cells"",
""Intestinal Stem Cells (ISCs) in Proliferative State"",
""Activated Fibroblasts / Mesenchymal Cells""
],
""possible_mixed_cell_types"": []
}
```"
